Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Other solid neoplasm 1

Conditions

Melanoma 146Carcinoma, Non-Small-Cell Lung 112Carcinoma, Renal Cell 74Neoplasm Metastasis 53Carcinoma, Hepatocellular 51Squamous Cell Carcinoma of Head and Neck 50Lung Neoplasms 48Colorectal Neoplasms 34Pancreatic Neoplasms 30Neoplasms 30Hodgkin Disease 30Urinary Bladder Neoplasms 24Sarcoma 23Brain Neoplasms 23Stomach Neoplasms 22Head and Neck Neoplasms 21Breast Neoplasms 21Prostatic Neoplasms 20Carcinoma, Transitional Cell 20Glioblastoma 19Recurrence 17Colonic Neoplasms 17Kidney Neoplasms 16Uveal Melanoma 15Small Cell Lung Carcinoma 15Multiple Myeloma 15Esophageal Neoplasms 15Carcinoma, Squamous Cell 14Skin Neoplasms 13Leukemia, Myeloid, Acute 13

Interventions

Bevacizumab 17Capecitabine 13Cetuximab 10Oxaliplatin 8Irinotecan 8Fluorouracil 7Panitumumab 5Leucovorin 4trifluridine tipiracil drug combination 3sintilimab 3regorafenib 3Nivolumab 3Ipilimumab 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Folfox protocol 2Drug Therapy 2spartalizumab 1pembrolizumab 1irinotecan sucrosofate 1glucopyranosyl lipid-A 1folfirinox 1camrelizumab 1balstilimab 1anisodamine 1aflibercept 1XELOX 1Vemurafenib 1Tyrosine Kinase Inhibitors 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Colorectal Cancer Metastatic × Nivolumab × Clear all
NCT04730544 2025-06-13

NIPISAFE

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Active not recruiting
96 enrolled
GastrointestinalOther solid neoplasm

Colorectal Cancer Metastatic

NCT04721301 2023-10-17

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

University Hospital Heidelberg

Phase 1 Completed
50 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03982121 2020-02-17

ISILI

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Withdrawn
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡